TCL Archive PR firm Edelman worked for a tobacco company and the National Dialogue on Cancer, despite a promise to the Dialogue that Edelman companies would no longer serve tobacco clients. July 25, 2003
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014